StockNews.AI
EHC
StockNews.AI
5 hrs

ENCOMPASS (EHC) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Encompass Health Corporation on Behalf of Encompass Stockholders and Encourages Investors to Contact the Firm

1. Investigation launched against Encompass by a law firm for potential violations. 2. Allegations of below-average safety measures in Encompass-operated hospitals. 3. Stock price of Encompass fell by 10.4% following investigative news. 4. 34 facilities rated poorly on preventable readmissions by Medicare. 5. Investors encouraged to seek legal advice regarding potential losses.

4m saved
Insight
Article

FAQ

Why Very Bearish?

The ongoing investigation and negative press have already led to a 10.4% drop in stock price. Similar situations in the past have resulted in sustained declines for companies facing legal scrutiny.

How important is it?

Given the serious nature of the allegations and the public's investment interest, this news directly impacts EHC’s reputation and stock performance.

Why Long Term?

Legal issues and reputational damage can take time to resolve, prolonging investor concerns. Companies in similar situations often face prolonged stock recovery times.

Related Companies

HCACYHLPNT
Bragar Eagel & Squire, P.C. Litigation Partners Encourage Investors Who Suffered Losses In Encompass (EHC) To Contact Them Directly To Discuss Their Options If you purchased or acquired securities in Encompass and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Encompass Health Corporation (“Encompass” or the “Company”) (NYSE:EHC) on behalf of Encompass stockholders. Our investigation concerns whether Encompass has violated the federal securities laws and/or engaged in other unlawful business practices. Investigation Details: On July 15, 2025, The New York Times published an article alleging, among other things, that federal data and inspection reports show that for-profit hospitals run by Encompass perform below average on key safety measures. The article revealed “Encompass owns many of the rehabs with worse rates of potentially preventable, unplanned readmissions to general hospitals” including 34 facilities which “Medicare rated as having statistically significantly worse rates of potentially preventable readmissions.” The report further revealed a number of “alarming mistakes” leading to fatalities of patients in their care.On this news, Encompass’s stock price fell $12.39, or 10.4%, to close at $107.28 per share on July 15, 2025, thereby injuring investors. Next Steps: If you purchased or otherwise acquired Encompass shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form.  There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, P.C.Brandon Walker, Esq.Marion Passmore, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com

Related News